SynthesisCurrent opinion in allergy and clinical immunology2026
Update on occupational contact urticaria: a systematic narrative review.
Synthesis in Current opinion in allergy and clinical immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewOccupational contact urticaria (OCU) is an immediate-type skin reaction triggered by chemicals or proteins encountered in the workplace. It is classified as either nonimmunologic (irritant) or immunologic (IgE-mediated), which differ in pathogenesis, diagnostic approach, and clinical severity. Immunologic OCU may present with generalized urticaria and even anaphylaxis. We conducted a systematic narrative review to provide an updated overview of OCU, integrating findings from a structured literature search (2017-2025) with expert clinical interpretation. This review synthesizes knowledge on causative agents, diagnostic strategies, and management approaches, with a focus on emerging occupational exposures. RECENT
findingsThe spectrum of occupational allergens continues to expand, with new reports implicating Cannabis sativa , arthropods (e.g., Anisakis simplex , pine processionary caterpillar), mask materials such as polypropylene, disinfectants (e.g., chloramine-T), antiseptics (e.g., chlorhexidine), cosmetic ingredients (e.g., henna, indigo, and hydrolyzed wheat protein), and enzymes (e.g., alpha-amylase, cellulase, papain, protease, and xylanase). Despite novel exposures, traditional culprits like natural rubber latex, ammonium persulfate, and animal-and plant-derived foods remain prevalent. SUMMARY: Early recognition, diagnostic testing, and prevention are essential to reduce systemic involvement and occupational disability. Strengthening workplace awareness, surveillance programs, and systematic occupational health, safety, and environmental management remains essential to reducing this preventable condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.